US Stock MarketDetailed Quotes

Impact BioMedical (IBO)

Watchlist
  • 0.4708
  • -0.0041-0.86%
Trading Jan 16 12:06 ET
49.26MMarket Cap-0.13P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Impact BioMedical (IBO) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
38.76%-613K
-80.26%-694K
-41.49%-682K
-37.46%-3.92M
-373.67%-2.05M
-49.18%-1M
47.48%-385K
52.47%-482K
-27.16%-2.85M
-19.28%-433K
Net income from continuing operations
-134.74%-1.47M
-1,527.32%-14.35M
-28.06%-1.28M
-462.06%-24.77M
-2,051.70%-27.13M
460.49%4.24M
21.25%-882K
-17.55%-998K
39.26%-4.41M
62.54%-1.26M
Depreciation and amortization
2.49%288K
3.23%288K
1.07%283K
-0.09%1.12M
-0.36%279K
0.36%281K
-0.36%279K
0.00%280K
0.63%1.12M
0.72%280K
Deferred tax
----
----
----
--33K
----
----
----
----
--0
----
Other non cash items
-7.75%262K
60.14%450K
17.83%271K
---5.07M
---5.86M
--284K
--281K
--230K
----
----
Change In working capital
130.22%42K
109.52%6K
83.33%11K
-239.45%-608K
-175.18%-412K
-161.50%-139K
-158.88%-63K
101.35%6K
3.56%436K
8.73%548K
-Change in receivables
-111.72%-15K
----
----
200.00%128K
--0
36.17%128K
----
----
---128K
---128K
-Change in inventory
--1K
----
----
----
----
--0
----
----
----
----
-Change in prepaid assets
89.16%-35K
102.50%1K
4,950.00%97K
-354.81%-265K
4.17%100K
-559.18%-323K
-129.41%-40K
97.47%-2K
273.33%104K
328.57%96K
-Change in payables and accrued expense
62.50%91K
91.30%-2K
-1,175.00%-86K
-202.39%-471K
-188.28%-512K
-69.06%56K
-135.38%-23K
102.19%8K
-4.37%460K
6.23%580K
Cash from discontinued investing activities
Operating cash flow
38.76%-613K
-80.26%-694K
-41.49%-682K
-37.46%-3.92M
-373.67%-2.05M
-49.18%-1M
47.48%-385K
52.47%-482K
-27.16%-2.85M
-19.28%-433K
Investing cash flow
Cash flow from continuing investing activities
0.00%1K
0
1K
113.33%2K
0
200.00%1K
109.09%1K
0
95.70%-15K
100.36%1K
Net PPE purchase and sale
----
----
----
--0
--0
--0
--0
--0
93.48%-18K
--0
Net other investing changes
0.00%1K
--0
--1K
-33.33%2K
--0
--1K
----
----
137.50%3K
0.00%1K
Cash from discontinued investing activities
Investing cash flow
0.00%1K
--0
--1K
113.33%2K
--0
200.00%1K
109.09%1K
--0
95.70%-15K
100.36%1K
Financing cash flow
Cash flow from continuing financing activities
0
0
0
106.46%5.92M
495.69%1.38M
321.38%3.67M
-48.53%384K
-52.51%483K
12.49%2.87M
-56.96%232K
Net issuance payments of debt
--0
--0
--0
-23.60%2.19M
495.69%1.38M
-106.90%-60K
-48.53%384K
-52.51%483K
12.49%2.87M
-56.96%232K
Net common stock issuance
----
----
----
--3.73M
--0
----
----
----
--0
--0
Cash from discontinued financing activities
Financing cash flow
--0
--0
--0
106.46%5.92M
495.69%1.38M
321.38%3.67M
-48.53%384K
-52.51%483K
12.49%2.87M
-56.96%232K
Net cash flow
Beginning cash position
31,100.00%624K
65,800.00%1.32M
199,800.00%2M
-50.00%1K
1,227.36%2.67M
-33.33%2K
100.00%2K
-50.00%1K
-95.65%2K
99.01%201K
Current changes in cash
-122.96%-612K
---694K
-68,200.00%-681K
199,900.00%2M
-234.50%-669K
1,246.46%2.67M
--0
200.00%1K
97.73%-1K
-102.02%-200K
End cash Position
-99.55%12K
31,100.00%624K
65,800.00%1.32M
199,800.00%2M
199,800.00%2M
1,227.36%2.67M
-33.33%2K
100.00%2K
-50.00%1K
-50.00%1K
Free cash flow
38.76%-613K
-80.26%-694K
-41.49%-682K
-36.60%-3.92M
-373.67%-2.05M
-48.96%-1M
48.32%-385K
52.70%-482K
-13.94%-2.87M
32.24%-433K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 38.76%-613K-80.26%-694K-41.49%-682K-37.46%-3.92M-373.67%-2.05M-49.18%-1M47.48%-385K52.47%-482K-27.16%-2.85M-19.28%-433K
Net income from continuing operations -134.74%-1.47M-1,527.32%-14.35M-28.06%-1.28M-462.06%-24.77M-2,051.70%-27.13M460.49%4.24M21.25%-882K-17.55%-998K39.26%-4.41M62.54%-1.26M
Depreciation and amortization 2.49%288K3.23%288K1.07%283K-0.09%1.12M-0.36%279K0.36%281K-0.36%279K0.00%280K0.63%1.12M0.72%280K
Deferred tax --------------33K------------------0----
Other non cash items -7.75%262K60.14%450K17.83%271K---5.07M---5.86M--284K--281K--230K--------
Change In working capital 130.22%42K109.52%6K83.33%11K-239.45%-608K-175.18%-412K-161.50%-139K-158.88%-63K101.35%6K3.56%436K8.73%548K
-Change in receivables -111.72%-15K--------200.00%128K--036.17%128K-----------128K---128K
-Change in inventory --1K------------------0----------------
-Change in prepaid assets 89.16%-35K102.50%1K4,950.00%97K-354.81%-265K4.17%100K-559.18%-323K-129.41%-40K97.47%-2K273.33%104K328.57%96K
-Change in payables and accrued expense 62.50%91K91.30%-2K-1,175.00%-86K-202.39%-471K-188.28%-512K-69.06%56K-135.38%-23K102.19%8K-4.37%460K6.23%580K
Cash from discontinued investing activities
Operating cash flow 38.76%-613K-80.26%-694K-41.49%-682K-37.46%-3.92M-373.67%-2.05M-49.18%-1M47.48%-385K52.47%-482K-27.16%-2.85M-19.28%-433K
Investing cash flow
Cash flow from continuing investing activities 0.00%1K01K113.33%2K0200.00%1K109.09%1K095.70%-15K100.36%1K
Net PPE purchase and sale --------------0--0--0--0--093.48%-18K--0
Net other investing changes 0.00%1K--0--1K-33.33%2K--0--1K--------137.50%3K0.00%1K
Cash from discontinued investing activities
Investing cash flow 0.00%1K--0--1K113.33%2K--0200.00%1K109.09%1K--095.70%-15K100.36%1K
Financing cash flow
Cash flow from continuing financing activities 000106.46%5.92M495.69%1.38M321.38%3.67M-48.53%384K-52.51%483K12.49%2.87M-56.96%232K
Net issuance payments of debt --0--0--0-23.60%2.19M495.69%1.38M-106.90%-60K-48.53%384K-52.51%483K12.49%2.87M-56.96%232K
Net common stock issuance --------------3.73M--0--------------0--0
Cash from discontinued financing activities
Financing cash flow --0--0--0106.46%5.92M495.69%1.38M321.38%3.67M-48.53%384K-52.51%483K12.49%2.87M-56.96%232K
Net cash flow
Beginning cash position 31,100.00%624K65,800.00%1.32M199,800.00%2M-50.00%1K1,227.36%2.67M-33.33%2K100.00%2K-50.00%1K-95.65%2K99.01%201K
Current changes in cash -122.96%-612K---694K-68,200.00%-681K199,900.00%2M-234.50%-669K1,246.46%2.67M--0200.00%1K97.73%-1K-102.02%-200K
End cash Position -99.55%12K31,100.00%624K65,800.00%1.32M199,800.00%2M199,800.00%2M1,227.36%2.67M-33.33%2K100.00%2K-50.00%1K-50.00%1K
Free cash flow 38.76%-613K-80.26%-694K-41.49%-682K-36.60%-3.92M-373.67%-2.05M-48.96%-1M48.32%-385K52.70%-482K-13.94%-2.87M32.24%-433K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.87%
Sample Name
Sample Code
 +3.15%
Sample Name
Sample Code
 +2.63%
4
Microsoft
MSFT
+0.96%
5
Block
XYZ
+0.85%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.28%
Sample Name
Sample Code
 +10.15%
Sample Name
Sample Code
 +9.38%
4
Kingsoft Cloud
KC
+7.35%
5
United Microelectronics
UMC
+5.97%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -